Dr. Siddiqi earned his PhD in Biochemistry from Banaras Hindu University (India). During his PhD, he isolated a new Salmonella bacteriophage named MB78.
Dr. Siddiqi completed his postdoctoral fellowship at MIT and Harvard Medical School, Boston. During his postdoctoral work, he isolated a novel gene for early detection of breast cancer. This gene/protein (DF3-CEA) is shed in any body fluid such as milk, urine, and saliva.
Dr. Siddiqi also worked as a junior faculty at Lombardi Cancer Research Centre, Georgetown University, where he isolated a novel gene that provided resistance to radiation therapy for head and neck cancer.
At Life Technologies (now ThermoFisher), Dr. Siddiqi worked on R&D and product development of non-PCR based rapid detection of human papilloma virus (HPV) and hepatitis B virus (HBV).
Dr. Siddiqi was also founder of two biotech companies: DNA Technologies, Inc. (sold) and Luminous BioSciences, LLC (current). Dr. Siddiqi has over 40 years of experience in research & corporate management.